Vanda Pharmaceuticals (VNDA) Gross Margin Growth (3y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 7,249.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -191.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -33.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -480.00 |
| 10 | Vanda Pharmaceuticals | 379.35 Mn | 177.04 Mn | 48.56 Mn | 153.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 153.00 |
| Dec 31, 2025 | 297.00 |
| Sep 30, 2025 | 442.00 |
| Jun 30, 2025 | 421.00 |
| Mar 31, 2025 | 238.00 |
| Dec 31, 2024 | 430.00 |
| Sep 30, 2024 | 434.00 |
| Jun 30, 2024 | 426.00 |
| Mar 31, 2024 | 237.00 |
| Dec 31, 2023 | 183.00 |
| Sep 30, 2023 | 189.00 |
| Jun 30, 2023 | 180.00 |
| Mar 31, 2023 | 134.00 |
| Dec 31, 2022 | 54.00 |
| Sep 30, 2022 | 173.00 |
| Jun 30, 2022 | 137.00 |
| Mar 31, 2022 | 130.00 |
| Dec 31, 2021 | 152.00 |
| Sep 30, 2021 | 62.00 |
| Jun 30, 2021 | 134.00 |
| Mar 31, 2021 | 84.00 |
| Dec 31, 2020 | 134.00 |
| Sep 30, 2020 | 117.00 |
| Jun 30, 2020 | 137.00 |
| Mar 31, 2020 | 172.00 |
| Dec 31, 2019 | 357.00 |
| Sep 30, 2019 | 676.00 |
| Jun 30, 2019 | 724.00 |
| Mar 31, 2019 | 719.00 |
| Dec 31, 2018 | 869.00 |
| Sep 30, 2018 | 1,265.00 |
| Jun 30, 2018 | 990.00 |
| Mar 31, 2018 | 1,218.00 |
| Dec 31, 2017 | -638.00 |
| Sep 30, 2017 | -619.00 |
| Jun 30, 2017 | -895.00 |